This specific ISBN edition is currently not available.View all copies of this ISBN edition:
As governments seek to mitigate the cost of state-subsidized healthcare, branding in the pharmaceutical industry has become a critical issue. Drugs companies must change their methods of communication and distribution--focusing more on their direct relationship with the consumer. This requires fundamental changes in consumer behavior, access to information, freedom of choice, and value for money. Brands and brand values will play a leading role in this process, as has been seen with products such as Prozac and Viagra. This book by Interbrand Newell and Sorrell, the world's leading branding consultancy, provides cutting-edge thinking on this area and lessons for anyone involved in brand development and management.
"synopsis" may belong to another edition of this title.
Tom Blackett is Group Deputy Chairman of Interbrand. He is the author of, Trademarks and the co-author of, Co-Branding, both published by Palgrave.
Rebecca Robins is a Senior Consultant of Interbrand Healthcare in New York. Prior to joining the New York office, she worked in the London office of Interbrand for four years.
"About this title" may belong to another edition of this title.
Book Description Palgrave Macmillan, 2001. Hardcover. Condition: New. Never used!. Seller Inventory # P110333930983
Book Description Palgrave Macmillan, 2001. Hardcover. Condition: New. Seller Inventory # DADAX0333930983
Book Description Palgrave Macmillan, 2001. Hardcover. Condition: New. Ships with Tracking Number! INTERNATIONAL WORLDWIDE Shipping available. Buy with confidence, excellent customer service!. Seller Inventory # 0333930983n